Peptides and Psychiatry, Part 1: How Synthesis of Neuropeptides Differs From Classical Neurotransmitter Synthesis
J Clin Psychiatry 1999;60(1):5-6
© Copyright 2014 Physicians Postgraduate Press, Inc.
Purchase This PDF for $40.00
If you are not a paid subscriber, you may purchase the PDF.
(You'll need the free Adobe Acrobat Reader.)
Receive immediate full-text access to JCP. You can subscribe to JCP online-only ($86) or print + online ($156 individual).
With your subscription, receive a free PDF collection of the NCDEU Festschrift articles. Hurry! This offer ends December 31, 2011.
If you are a paid subscriber to JCP and do not yet have a username and password, activate your subscription now.
As a paid subscriber who has activated your subscription, you have access to the HTML and PDF versions of this item.
Click here to login.
Did you forget your password?
Still can't log in? Contact the Circulation Department at 1-800-489-1001 x4 or send email
This is the first of a 3-part series on peptides and psychiatry. Part 1 is a visual lesson on molecular aspects of how these interesting neurotransmitters are synthesized, stored, and released. Part 2 will appear in the February 1999 BRAINSTORMS and will explore a very exciting family of neuropeptides with potentially important therapeutic activities, namely the tachykinins, also called neurokinins, of which substance P is the best known example.